Baba Farid University Dental Journal
  • Year: 2022
  • Volume: 12
  • Issue: 1

Outcome of direct pulp capping in young permanent molars with three different pulp capping agents: An in vivo study

  • Author:
  • Akanksha Sood1, Nisha Garg2,*, Ajay Chhabra3, Ankita Sood4, Suvaani Kataria1, Vandana Chhabra6
  • Total Page Count: 4
  • Page Number: 34 to 37

1Consultant Endodontist, Chandigarh, India

2Prof, Dept. of Conservative Dentistry and Endodontics, Bhojia Dental College and Hospital, Baddi, Himachal Pradesh, India

3Prof. and Head, Dept. of Dentistry, All India Institute of Medical Sciences, Kalyani, West Bengal, India

4General Dentist, Chandigarh, India

6Associate Professor, H.S. Judge Institute of Dental Sciences and Hospital, Chandigarh, India

*Corresponding Author: Dr. Nisha Garg, Prof, Dept. of Conservative Dentistry and Endodontics, Bhojia Dental College and Hospital, Baddi, Himachal Pradesh, India Email: drnishagarg1@gmail.com

Online published on 15 September, 2022.

Abstract

In vivo comparison of direct pulp capping with three different pulp capping agents in permanent molars.

A total of ninety samples were included in this study. The patients were aged between 15–30 yrs. Patientsd with deep carious lesions approaching the pulp were selected. The patients were randomly divided into 3 groups: Group I Calcium hydroxide (n=30), Group II MTA (n=30), Group III TheraCal LC(n=30).The teeth were assessed clinically and radiographically after 3 months and 1 year for dentin bridge formation and other signs and symptoms.

The study showed that TheraCal LChad slightly better results than MTA and calcium hydroxide. Kaplan-Meier survival analysis showed a mean overall pulp survival time of 10.2 months for direct pulp capping. The present study reported a cumulative success rate of direct pulp capping with all three experimental pulp capping agents to be 85.8% at 1 year.

These findings suggest that DPC is an excellent treatment option for young permanent molars.

Keywords

Vital pulp therapy, Dycal, MTA, TheraCal LC